Anagenics Limited (ASX:AN1) Annual Report 2021



The latest annual report of Anagenics Limited (AN1) was published on 30 Jun 2021. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - AN1 Annual Results

Amounts in AUD

Total Revenue
5.82M
Gross Profit
3.7M
EBIT
-3.25M
Net Tangible Assets
8.96M
Net Income
-3.39M
Capital Expenditures
-22.47k

AN1 Income Statement 2021 Annual Report

As per the latest Income Statement of AN1, the Net revenue decreased by $-1.53M (-21%) compared to the previous period. The operating income in 2021 increased by $925635 (22%). The net income as per the annual report was -3.39M which increased by $1.52M (31%) compared to previous year.

Income Statement Report (2021/2020)

20212020
Total Revenue5.82M7.34M
Gross Profit3.7M4.85M
Operating Income-3.25M-4.18M
Income Before Tax-3.76M-4.27M
Net Income-3.39M-4.91M

Balance Sheet - AN1 2021 Annual Report

Read further: AN1 Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Anagenics Limited showed the company reduced the cash on balance sheet by $-243203 (-3%). The Net tangible assets of AN1 on the balance sheet were at 8.96M which is $902733 (11%) more than previous annual report. The total stockholder equity also increased by $623669 (6%) compared to previous reporting period.

Balance Sheet Statement Report (2021/2020)

20212020
Cash6.73M6.97M
Total Assets13.29M 14.89M
Long Term Debt601.4k876.25k
Total Liabilities2.86M 5.08M
Total Shareholder Equity10.43M9.81M
Net Tangible Assets8.96M8.05M

Cash Flow Statement - AN1 2021 Annual Report

The 2021 annual cash flow statement of Anagenics Limited showed that the net income increased by $1.52M (31%) compared to previous reporting period. Also the capital expenditure of AN1 increased by $0 (0%).

As of 2021, the total cash from investing activities was 477.53k and total cash from financing activities was 3.5M.

Cash Flow Statement Report (2021/2020)

20212020
Net Income-3.39M-4.91M
Capital Expenditures-22.47k-22.47k
Dividends Paid--
Total Cash From From Investing Activities477.53k477.53k
Total Cash From From Financing Activities3.5M7.98M

Anagenics Limited Annual Report History

Income Statement

Income Statement history of Anagenics Limited (ASX:AN1)

30 Jun 202130 Jun 202030 Jun 201930 Jun 2018
Total Revenue5.82M7.34M7.39M5.74M
Cost Of Revenue2.11M2.5M2.14M2.17M
Gross Profit3.7M4.85M5.25M3.57M
Research Development118.79k399.52k848.47k619.02k
Selling General Administrative5.96M8.07M9.7M6.35M
Non Recurring----
Other Operating Expenses880.34k562.5k386.26k-172.17k
Total Operating Expenses9.07M11.52M13.07M8.97M
Operating Income-3.25M-4.18M-5.68M-3.23M
Total Other Income Expense Net-506.84k-88.34k-201.22k-504.73k
Ebit-3.25M-4.18M-5.68M-3.23M
Interest Expense-54.76k-71.26k-235.04k-473.27k
Income Before Tax-3.76M-4.27M-5.89M-3.73M
Income Tax Expense45.05k89.47k24.11k2.43k
Minority Interest----
Net Income From Continuing Ops-3.8M-4.36M-5.91M-3.73M
Discontinued Operations418.3k-550.8k-550.8k-550.8k
Extraordinary Items----
Effect Of Accounting Charges----
Other Items----
Net Income-3.39M-4.91M-5.91M-3.73M
Net Income Applicable To Common Shares-3.39M-4.91M-5.91M-3.73M

Balance Sheet Statement

Balance Sheet Statement history of Anagenics Limited (ASX:AN1)

30 Jun 202130 Jun 202030 Jun 201930 Jun 2018
Cash6.73M6.97M3.08M1.61M
Net Receivables1.8M1.87M2.29M1.03M
Inventory2.55M2.61M1.62M1.18M
Total Current Assets11.29M11.63M7.23M4.16M
Property Plant Equipment527.28k1.5M800.24k770.99k
Intangible Assets1.48M1.76M1.76M1.82M
Total Assets13.29M14.89M9.79M6.75M
Accounts Payable682.19k839.73k685.22k603.76k
Short Long Term Debt229.68k253.75k266.8k2.01M
Other Current Liab381.49k1.93M1.74M935.98k
Long Term Debt601.4k876.25k1.02M1.17M
Other Liab99.51k97.27k6.74k4.44k
Total Current Liabilities1.92M3.64M2.91M3.72M
Total Liab2.86M5.08M3.93M4.89M
Common Stock60.28M56.06M47.77M38.01M
Retained Earnings-50.78M-47.39M-42.54M-38.74M
Treasury Stock931.77k1.14M632.35k2.58M
Other Stockholder Equity931.77k1.14M632.35k2.58M
Total Stockholder Equity10.43M9.81M5.86M1.86M
Net Tangible Assets8.96M8.05M4.1M36.67k

Cash Flow Statement

Cash Flow Statement history of Anagenics Limited (ASX:AN1)

30 Jun 202130 Jun 202030 Jun 201930 Jun 2018
Net Income-3.39M-4.91M-5.91M-3.73M
Depreciation434.63k518.66k152.89k187.54k
Change To Netincome124.64k657.32k461.62k209.81k
Change To Account Receivables146.47k321.5k-1.26M-653.06k
Change To Liabilities-168.56k4241.18M284.06k
Change To Inventory-274.16k-990.95k-355.37k-101.41k
Change To Operating Activities-1.01M387.24k51.79k-357.97k
Total Cash From Operating Activities-4.11M-4.01M-5.67M-4.16M
Capital Expenditures-22.47k-22.47k-65.68k-107.17k
Other Cashflows From Investing Activities500k500k500k500k
Total Cashflows From Investing Activities477.53k477.53k-65.68k-107.17k
Net Borrowings-579.39k-260.02k-1.99M903.48k
Other Cashflows From Financing Activities-433.75k-607.09k-733.79k-384.93k
Total Cash From Financing Activities3.5M7.98M7.27M1.84M
Effect Of Exchange Rate-105.17k-77.75k-63.78k39.42k
Change In Cash-243.2k3.89M1.47M-2.39M
Issuance Of Stock4.51M8.85M10.11M1.33M
Dividends Paid----